FDA Expands Oversight of Cell and Gene Therapies

被引：0

|

作者：

Wechsler, Jill

机构：

来源：

BIOPHARM INTERNATIONAL | 2022年 / 35卷 / 11期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：9 / 9

页数：1

相关论文

共 50 条

[41] FDA Expands Warning on Diet Products
Voelker, Rebecca
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (16): : 1646 - 1646
[42] FDA expands "healthy" label definition
不详
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1998, 98 (06) : 634 - 634
[43] Edible Cannabis Products: It Is Time for FDA Oversight
Benjamin, David M.
Fossler, Michael J.
JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (09): : 1045 - 1047
[44] Texas legitimizes path around FDA oversight
Laura DeFrancesco
Nature Biotechnology, 2012, 30 : 379 - 379
[45] FDA enhances oversight of postmarket drug safety
Reactions Weekly, 2012, 1400 (1) : 2 - 2
[46] FDA bioproduct oversight shifts to drug division
Wong, JF
GENETIC ENGINEERING NEWS, 2002, 22 (17): : 55 - +
[47] FDA's Framework for Regulatory Oversight of LDTs
Pathak, Bhagyashri
Terry, Sharon F.
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2014, 18 (12) : 785 - 786
[48] Outsourcing challenges FDA to strengthen oversight abroad
Torres, Christian
NATURE MEDICINE, 2010, 16 (02) : 139 - 139
[49] Texas legitimizes path around FDA oversight
DeFrancesco, Laura
NATURE BIOTECHNOLOGY, 2012, 30 (05) : 379 - 379
[50] Pandemic Alters FDA Inspections and Quality Oversight
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2021, 34 (11) : 8 - 9

← 1 2 3 4 5 →